Details of the Drug
General Information of Drug (ID: DMI3GIA)
| Drug Name |
F10
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
F10 (neutralizing antibody, group 1 influenza A infection); F10 (neutralizing antibody, group 1 influenza A infection), Harvard Medical School/Dana-Farber Cancer Institute/XOMA/SRI International; F10 (neutralizing antibody, H5N1/H1N1 infection), Harvard Medical School/Dana-Farber Cancer Institute/XOMA/SRI International
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug-Molecule Activity Atlas (DMA)NEW | Click to Jump to the Detailed DMA Information of This Drug | ||||||||||||||||||
| Drug Pharmacogenomic Perturbation (DPP)NEW | Click to Jump to the Detailed DPP Information of This Drug | ||||||||||||||||||
| Drug ADMET Endpoint Profile (DAE)NEW | Click to Jump to the Detailed DAE Information of This Drug | ||||||||||||||||||

